Testing effectiveness (Phase 2)Study completedNCT00620815
What this trial is testing
Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
Who this might be right for
Influenza
Novartis Vaccines 601